ImageneBio, Inc. (IMA) stock
IMANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$3.90+0.70 (+21.87%)
Close on Nov 17, 2026Market cap $44.27MP/E –Yield –
ImageneBio revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
ImageneBio's revenue for the twelve months ending Dec 31, 2025 was $800.00K, down 77.1% year over year. For fiscal 2025 it was $800.00K, down 77.1% from the year before. The highest annual figure on record is $30.99M in fiscal 2021.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $800.00K | -77.1% |
| FY2024 | Dec 31, 2024 | $3.50M | -61.8% |
| FY2023 | Dec 31, 2023 | $9.16M | -41.3% |
| FY2022 | Dec 31, 2022 | $15.62M | -49.6% |
| FY2021 | Dec 31, 2021 | $30.99M | +237.0% |
| FY2020 | Dec 31, 2020 | $9.19M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | $0 | – |
| Q3 FY2025 | Sep 30, 2025 | $0 | -100.0% |
| Q2 FY2025 | Jun 30, 2025 | $0 | -100.0% |
| Q1 FY2025 | Mar 31, 2025 | $800.00K | -32.5% |
| Q4 FY2024 | Dec 31, 2024 | $0 | -100.0% |
| Q3 FY2024 | Sep 30, 2024 | $3.50M | -34.1% |
| Q4 FY2023 | Dec 31, 2023 | $659.00K | -87.9% |
| Q3 FY2023 | Sep 30, 2023 | $1.19M | -81.5% |
| Q2 FY2023 | Jun 30, 2023 | $2.00M | +424.6% |
| Q1 FY2023 | Mar 31, 2023 | $5.31M | +57.0% |
| Q4 FY2022 | Dec 31, 2022 | $5.45M | -73.0% |
| Q3 FY2022 | Sep 30, 2022 | $6.40M | +70.9% |
| Q2 FY2022 | Jun 30, 2022 | $382.00K | -89.2% |
| Q1 FY2022 | Mar 31, 2022 | $3.38M | -2.6% |
| Q4 FY2021 | Dec 31, 2021 | $20.22M | +31003.1% |
| Q3 FY2021 | Sep 30, 2021 | $3.75M | +32.4% |
| Q2 FY2021 | Jun 30, 2021 | $3.55M | +15.5% |
| Q1 FY2021 | Mar 31, 2021 | $3.47M | +7.7% |
| Q4 FY2020 | Dec 31, 2020 | $65.00K | – |
| Q3 FY2020 | Sep 30, 2020 | $2.83M | – |
| Q2 FY2020 | Jun 30, 2020 | $3.07M | – |
| Q1 FY2020 | Mar 31, 2020 | $3.23M | – |
See a number that looks wrong?